Monitored anesthesia care with remimazolam for gynecological day surgeries: Case reports

Abstract Remimazolam is a newly approved benzodiazepine characterized by rapid onset, predictable maintenance, fast recovery, and availability of a reversal agent. We describe four cases of patients who received monitored anesthesia care with remimazolam for gynecological day surgery.

Bibliographic Details
Main Authors: So Ron Choi, Tae Hyung Kim, Deuk Won Eom, Ji Wook Jung, Sang Yoong Park
Format: Article
Language:English
Published: Wiley 2022-11-01
Series:Clinical Case Reports
Subjects:
Online Access:https://doi.org/10.1002/ccr3.6536